Metabolomics: Unraveling the chemical individuality of common human diseases

References

• Idle JR, Gonzalez FJ. Metabolomics. Cell Metab. 2007; 6: 348–51
   PubMed Web of Science ®Google Scholar
• Lanpher B, Brunetti-Pierri N, Lee B. Inborn errors of metabolism: the flux from Mendelian to complex diseases. Nat Rev Genet. 2006; 7: 449–60
   PubMed Web of Science ®Google Scholar
• Scriver CR. Garrod's foresight; our hindsight. J Inherit Metab Dis. 2001; 24: 93–116
   Google Scholar
• Scriver CR. After the genome—the phenome?. J Inherit Metab Dis. 2004; 27: 305–17
   Google Scholar
• Vangala S, Tonelli A. Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity?. AAPS J. 2007; 9: E284–97
   Google Scholar
• Prasad C, Galbraith PA. Sir Archibald Garrod and alkaptonuria—‘story of metabolic genetics’. Clin Genet. 2005; 68: 199–203
   Google Scholar
• Burgio GR. ‘Inborn errors of metabolism’ and ‘chemical individuality’, two ideas of Sir Archibald Garrod briefly revisited 50 years after his death. Eur J Pediatr. 1986; 145: 2–5
   PubMed Web of Science ®Google Scholar
• Childs B. Sir Archibald Garrod's conception of chemical individuality: a modern appreciation. N Engl J Med. 1970; 282: 71–7
   Google Scholar
• Garrod AE. The incidence of alkaptonuria: a study in chemical individuality. Lancet. 1902; 2: 1616–20
   Google Scholar
• Garrod AE. The incidence of alkaptonuria: a study in chemical individuality. Mol Med. 1996; 2: 274–82
   PubMedGoogle Scholar
• Bergmeyer HU, Bergmeyer J, Grassl M. Methods of enzymatic analysis3 ed. VCH Verlagsgesellschaft mbH, Weinheim 1986
   Google Scholar
• Weckwerth W, Morgenthal K. Metabolomics: from pattern recognition to biological interpretation. Drug Discov Today. 2005; 10: 1551–8
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 2008; 48: 653–83
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002; 1: 153–61
   PubMed Web of Science ®Google Scholar
• Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 2008; 453: 396–400
   PubMed Web of Science ®Google Scholar
• Stamler J, Elliott P, Dennis B, Dyer AR, Kesteloot H, Liu K, et al. INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertens. 2003; 17: 591–608
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Holmes E, Elliott P. The metabolome-wide association study: a new look at human disease risk factors. J Proteome Res. 2008; 7: 3637–8
   PubMed Web of Science ®Google Scholar
• Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, Richardson TA, et al. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab. 2008; 7: 135–47
   PubMed Web of Science ®Google Scholar
• Kim YC, Ntambi JM. Regulation of stearoyl-CoA desaturase genes: role in cellular metabolism and preadipocyte differentiation. Biochem Biophys Res Commun. 1999; 266: 1–4
   PubMed Web of Science ®Google Scholar
• Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008; 7: 45–56
   PubMed Web of Science ®Google Scholar
• Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem. 2003; 49: 1797–817
   PubMed Web of Science ®Google Scholar
• Costa CC, de Almeida I, Jakobs C, Poll-The BT, Duran M. Dynamic changes of plasma acylcarnitine levels induced by fasting and sunflower oil challenge test in children. Pediatr Res. 1999; 46: 440–4
   PubMed Web of Science ®Google Scholar
• Muoio DM, Koves TR. Lipid-induced metabolic dysfunction in skeletal muscle. Novartis Found Symp. 2007; 286: 24–38
   Google Scholar
• Hellerstein MK. In vivo measurement of fluxes through metabolic pathways: the missing link in functional genomics and pharmaceutical research. Annu Rev Nutr. 2003; 23: 379–402
   Google Scholar
• Landau BR. Quantifying the contribution of gluconeogenesis to glucose production in fasted human subjects using stable isotopes. Proc Nutr Soc. 1999; 58: 963–72
   Google Scholar